Search Results - "Bom, Anton H."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats by Staals, Lonneke M., de Boer, Hans D., van Egmond, Jan, Hope, Frank, van de Pol, Francien, Bom, Anton H., Driessen, Jacques J., Booij, Leo H. D. J.

    Published in Journal of anesthesia (01-04-2011)
    “…Purpose Sugammadex is a selective relaxant binding agent designed to encapsulate the aminosteroidal neuromuscular blocking agent rocuronium, thereby reversing…”
    Get full text
    Journal Article
  2. 2

    Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey by Staals, Lonneke M, van Egmond, Jan, Driessen, Jacques J, de Boer, Hans D, van de Pol, Francien, Bom, Anton H, Booij, Leo HDJ

    Published in European journal of anaesthesiology (01-04-2011)
    “…BACKGROUND AND OBJECTIVE3-Desacetyl-vecuronium is an active metabolite of the neuromuscular blocking agent (NMBA) vecuronium, which might lead to residual…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Effects of 5-hydroxytryptamine on capillary and arteriovenous anastomotic blood flow in the human hand and forearm and in the pig hind leg by Blauw, G, Bom, A H, van Brummelen, P, Camps, J, Arndt, J W, Verdouw, P D, Chang, P C, van Zwieten, P A, Saxena, P R

    Published in Journal of cardiovascular pharmacology (01-02-1991)
    “…The effects of intraarterially infused serotonin (5-HT) on capillary and arteriovenous anastomotic (AVA) blood flow were investigated in the hand and forearm…”
    Get more information
    Journal Article
  5. 5

    Carotid haemodynamics in pigs during infusions of 8‐O‐DPAT: reduction in arteriovenous shunting is mediated by 5‐HT1‐like receptors by Bom, Anton H., Verdouw, Pieter D., Saxena, Pramod R.

    Published in British journal of pharmacology (01-01-1989)
    “…1 The effects of intracarotid infusions of 8‐hydroxy‐2‐[di‐n‐propyl‐amino]‐tetralin (8‐OH‐DPAT) on heart rate, blood pressure and carotid blood flow and its…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5‐HT 1 ‐like or 5‐HT 2 receptors by Bom, Anton H., Heiligers, Jan P.C., Saxena, Pramod R., Verdouw, Pieter D.

    Published in British journal of pharmacology (01-06-1989)
    “…The potent, antimigraine drug ergotamine has affinity for both 5‐HT 1 and 5‐HT 2 binding sites and constricts arteriovenous anastomoses. Since 5‐HT also…”
    Get full text
    Journal Article
  8. 8

    Characterization of 5-hydroxytryptamine receptors in the cranial vasculature by Saxena, P R, Bom, A H, Verdouw, P D

    Published in Cephalalgia (01-01-1989)
    “…The availability of selective compounds has made it possible to subdivide 5-hydroxytryptamine (5-HT) receptors into three distinct types, called 5-HT1-like,…”
    Get more information
    Journal Article
  9. 9

    The 5-HT1-like receptor mediating reduction of porcine carotid arteriovenous shunting by RU 24969 is not related to either the 5-HT1A or the 5-HT1B subtype by Bom, A H, Villalón, C M, Verdouw, P D, Saxena, P R

    Published in European journal of pharmacology (14-11-1989)
    “…Using the radioactive microsphere technique in anaesthetized pigs, we studied the systemic and carotid haemodynamic effects of intracarotid infusions (0.3, 1,…”
    Get more information
    Journal Article
  10. 10

    Effects of S9977 and dihydroergotamine in an animal experimental model for migraine by Villalón, C M, Bom, A H, Den Boer, M O, Heiligers, J P, Saxena, P R

    Published in Pharmacological research (01-02-1992)
    “…The present study concerns the effects of S9977, a trimethylxanthine derivative with potential antimigraine characteristics, on the distribution of carotid…”
    Get more information
    Journal Article
  11. 11

    Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of «5-hydroxytryptamine1-like» receptors by SAXENA, P. R, DUNCKER, D. J, BOM, A. H, HEILIGERS, J, VERDOUW, P. D

    “…The present study concerns the effects of MDL 72222 (0.5 mg X kg-1, i.v.), a 5-hydroxytryptamine3 (5-HT3) receptor antagonist, and methiothepin (1.0 mg X kg-1,…”
    Get full text
    Journal Article
  12. 12

    Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5‐HT1‐like or 5‐HT2 receptors by Bom, Anton H., Heiligers, Jan P.C., Saxena, Pramod R., Verdouw, Pieter D.

    Published in British journal of pharmacology (01-06-1989)
    “…1 The potent, antimigraine drug ergotamine has affinity for both 5‐HT1 and 5‐HT2 binding sites and constricts arteriovenous anastomoses. Since 5‐HT also…”
    Get full text
    Journal Article